Ventyx Biosciences Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress GlobeNewswire August 07, 2025 Positive topline Phase 2a biomarker data position VTX3232 as a potential disease-modifying therapy for patients with Parkinson's disease Data from the Phase 2 study of VTX2735 in patients with recurrent pericarditis expected in Q4 2025 Phase 2 study […]
RxSight, Inc. Reports Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 ALISO VIEJO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended June 30, 2025. Key
Rackspace Technology Reports Second Quarter 2025 Results GlobeNewswire August 07, 2025 Revenue of $666 million in the Second Quarter, down 3% Year-over-Year Private Cloud Revenue was $250 million, down 4% Year-over-Year Public Cloud Revenue was $417 million, down 2% Year-over-Year Second Quarter 2025 Cash Flow From Operating Activities was $8 million; Cash Flow From Operating
BeautyHealth Reports Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 Raises guidance on strong execution and disciplined cost management Advances science-backed innovation with successful launch of the HydraFillic with Pep9(TM) Booster LONG BEACH, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the “Company”), home to flagship brand
(NYSE:TSN), SPRINGDALE, Ark., Aug. 07, 2025 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (NYSE: TSN) announced today that its board of directors has declared a quarterly dividend of $0.50 per share on Class A common stock and $0.45 per share on Class B common stock, payable on December 15, 2025, to shareholders of record at the
(Other OTC:GLLI),(OTC US:GLLI),(OTC US:GLLIW),(Other OTC:GLLIW),(OTC US:GLLIR),(Other OTC:GLLIR),(OTC US:GLLIU),(Other OTC:GLLIU), New York, NY, Aug. 07, 2025 (GLOBE NEWSWIRE) — Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company“), a special purpose acquisition company, announced today that on August 5, 2025, it caused to be deposited $0.15 per public share, totaling $10,890.15 (the
Bridger Aerospace Announces Strongest Second Quarter in Company History Expanded Contracts and Increased Fire Activity Drive Record Revenue and Earnings GlobeNewswire August 07, 2025 BELGRADE, Mont., Aug. 07, 2025 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation's largest aerial firefighting companies, today
(NASDAQ:PLRX), BEACON-IPF close out activities continue Previously announced workforce and operational realignment largely complete Phase 1 oncology trial on track to deliver additional data by the end of the year SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in integrin-based drug development,
(NasdaqGM:QUMSU),(NasdaqGM:QUMS), NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Quantumsphere Acquisition Corporation (NASDAQ: QUMS, the “Company”) announced today that it has closed its initial public offering of 8,280,000 units at $10.00 per unit. This includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 1,080,000 units. Each
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation GlobeNewswire August 07, 2025 VALENCIA, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for the second quarter ended June